University of Ioannina
Συμβολή των μοριακών τεχνικών στη διάγνωση λοιμώξεων από κυτταρομεγαλοϊό (cytomegalovirus-CMV)
Abstract
dc:descriptionInfections with human cytomegalovirus (hCMV) are usually asymptomatic or related with harmless symptoms. Severe problems occur if fetuses, transplant patients, or patients under immunosuppressive therapy get infected.CMV infections in this risk group can even be fatal. The aim of this study was to investigate the impact of molecular assays (quantative PCR) for diagnosis and monitoring of an active CMV infection in immunocompetent and immunosupressed patients.A total of 260 patients were enrolled in this study, 145 males and 115 females (age range, 30 days to 88 years), who were hospitalized with clinical suspicion of CMV infection, in the University Hospital of Ioannina, during the period January 2007 to December 2011. Forty three children and 217 adults, 108 immunocompetent and 152 immunosupressed were screened for CMV-IgM antibody (AxSYM, Abbott) and CMV-DNA (Cobas Amplicor, Roche Diagnostics). The association between viral load in plasma and clinical data was also investigated. According to our results, the confirmation of CMV infection by the two methods (immunoassay and PCR) was obtained in 19 patients. Thirty-nine patients were positive for CMV-IgM and negative for CMV-DNA, where in 12 of them, antibodies for HSV, VZV, or EBV were also detected. By performing PCR, 17 extra cases of active infection were diagnosed, for which no antibodies could be detected.Totally, the CMV-DNA positive patients were 6 children and 30 adults. Hematological malignancies (n=14) under immunosuppressive therapy (non transplanted), was the underlying disease noted in the most patients.All CMV-DNA positive patients had clinical presentations compatible with active CMV infection. Among them pneumonitis was the most common (n=22). Overall, the median blood CMV viral load (VL) was 2410 copies/ml, while it was much lower in them with an infection mononucleosis-like syndrome, 593 copies/ml. Twenty five of the 36 CMV PCR positive patients received ganciclovir on the day that positivity was documented. The treatment led to a marked decrease in CMV DNA copy number. The median time interval necessary to obtain a negative result after implementation of treatment by CMV DNA PCR assay was 27 days (range, 13-40 days).In conclusion, quantative PCR CMV assay is sensitive, specific and rapid for quantifying CMV viral load, and it seems to be useful in the diagnosis and management of affected patients for predicting disease and monitoring response to antiviral therapy and can serve as surrogate markers for antiviral resistance and clinical relapse in these patients. Compared with traditional serologic assays that detect antibodies to CMV, quantative PCR offers a significant advance through the direct detection of viral DNA, which is independent of a functioning humoral immune system.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zotos, Nikolaos
- Ζώτος, Νικόλαος
Subjects
dc:subject × 20- Μοριακές τεχνικές
- Ανθρώπινος κυτταρομεγαλοϊός
- Αλυσιδωτή αντίδραση πολυμεράσης
- Ιικό φορτίο
- Ανίχνευση αντισωμάτων
- Αιματολογικές κακοήθειες
- Προσδιορισμός συνάφειας αντισωμάτων
- Ενζυμικός ανοσοπροσδιορισμός με μικροσωματίδια
- Molecular assays
- Human cytomegalovirus
- Polymerase chain reaction
- CMV IGG avidity
- Haematological malignacies
- Viral load
- IGG and IGM antibodies
- Microparticle enzyme immunoassay
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29040